| P50 | author | Laurent Savale | Q89807923 |
| | Walter Klepetko | Q56055212 |
| P2093 | author name string | Marc de Perrot | |
| | Christian Kühn | |
| | Paul Corris | |
| | Raymond L Benza | |
| | Elie Fadel | |
| | Marius M Hoeper | |
| | Anne M Keogh | |
| P2860 | cites work | Mechanical Support for the Failing Right Ventricle in Patients With Precapillary Pulmonary Hypertension | Q26799655 |
| | Physical rehabilitation for lung transplant candidates and recipients: An evidence-informed clinical approach | Q28079479 |
| | Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease | Q28273921 |
| | Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry | Q33608547 |
| | Importance of venous congestion for worsening of renal function in advanced decompensated heart failure | Q33799478 |
| | The importance of the gastrointestinal system in the pathogenesis of heart failure | Q34429097 |
| | 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): | Q34491530 |
| | Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review | Q35559191 |
| | Acute hemodynamic effects of adaptive servoventilation in patients with pre-capillary and post-capillary pulmonary hypertension | Q36253128 |
| | Left ventricular diastolic dysfunction in pulmonary hypertension predicts functional capacity and clinical worsening: a tissue phase mapping study | Q36416955 |
| | Predictors of cardiac hepatopathy in patients with right heart failure. | Q36516184 |
| | Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension | Q37343794 |
| | Optimising the management of pulmonary arterial hypertension patients: emergency treatments | Q37801174 |
| | Use of central venous oxygen saturation to guide therapy | Q37823041 |
| | Intensive care unit management of patients with severe pulmonary hypertension and right heart failure | Q37893845 |
| | Extracorporeal membrane oxygenation as a bridge to lung transplantation and recovery | Q38026263 |
| | Right ventricular assist device in end-stage pulmonary arterial hypertension: insights from a computational model of the cardiovascular system | Q38046308 |
| | Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation | Q38073455 |
| | Extracorporeal membrane oxygenation as a novel bridging strategy for acute right heart failure in group 1 pulmonary arterial hypertension | Q38168338 |
| | Novel and emerging therapies for pulmonary hypertension | Q38176678 |
| | A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. | Q38236174 |
| | Effect of the lung allocation score on lung transplantation in the United States | Q38409451 |
| | Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. | Q38642424 |
| | 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension | Q57823897 |
| | Atrial flutter and fibrillation in patients with pulmonary hypertension | Q57823980 |
| | Bridge to Thoracic Organ Transplantation in Patients with Pulmonary Arterial Hypertension Using a Pumpless Lung Assist Device | Q57824177 |
| | Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity | Q58801201 |
| | Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure* | Q59243982 |
| | Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs | Q72724279 |
| | Ten years experience with lung and heart-lung transplantation in primary and secondary pulmonary hypertension | Q73055162 |
| | Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure | Q80259405 |
| | Primary lung transplantation after bridge with extracorporeal membrane oxygenation: a plea for a shift in our paradigms for indications | Q83638780 |
| | Impact of extracorporeal life support on outcome in patients with idiopathic pulmonary arterial hypertension awaiting lung transplantation | Q83852084 |
| | Long-term outcome of double-lung and heart-lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients | Q84010239 |
| | Two axial-flow Synergy Micro-Pumps as a biventricular assist device in an ovine animal model | Q84975368 |
| | Comparison of extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation | Q86099455 |
| | Vasopressin decreases pulmonary-to-systemic vascular resistance ratio in a porcine model of severe hemorrhagic shock | Q86488496 |
| | Impact of Left Ventricular Diastolic Dysfunction on Lung Transplantation Outcome in Patients With Pulmonary Arterial Hypertension | Q88072872 |
| | Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018 | Q91320785 |
| | Lung Transplantation in Germany Since the Introduction of the Lung Allocation Score | Q38734226 |
| | Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology | Q38781987 |
| | State of the Art: Bridging to lung transplantation using artificial organ support technologies. | Q39028786 |
| | Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension. | Q40192628 |
| | Extracorporeal life support in lung and heart-lung transplantation for pulmonary hypertension in adults | Q40614559 |
| | Extracorporeal membrane oxygenation as a bridge to lung transplantation in the United States: an evolving strategy in the management of rapidly advancing pulmonary disease | Q41669246 |
| | Ischemic hepatitis: clinical presentation and pathogenesis | Q41758787 |
| | Transplantation for idiopathic pulmonary arterial hypertension: improvement in the lung allocation score era. | Q42600426 |
| | Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension. | Q43246249 |
| | Organ allocation waiting time during extracorporeal bridge to lung transplant affects outcomes. | Q43765342 |
| | Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations | Q44286521 |
| | Lung transplantation for severe pulmonary hypertension--awake extracorporeal membrane oxygenation for postoperative left ventricular remodelling | Q44434161 |
| | Awake extracorporeal membrane oxygenation bridging for pulmonary retransplantation provides comparable results to elective retransplantation. | Q44529803 |
| | Reverse cardiac remodelling in patients with primary pulmonary hypertension after isolated lung transplantation | Q45079900 |
| | Growing experience with extracorporeal membrane oxygenation as a bridge to lung transplantation | Q45095227 |
| | Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. | Q45140807 |
| | Functional impact of pulmonary hypertension due to hypoventilation and changes under noninvasive ventilation | Q45745115 |
| | Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study | Q45751023 |
| | The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report--2010. | Q45892834 |
| | Extracorporeal life support as a bridge to lung transplantation-experience of a high-volume transplant center. | Q47297459 |
| | Low-flow support of the chronic pressure-overloaded right ventricle induces reversed remodeling | Q47737054 |
| | A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension | Q47873724 |
| | Extracorporeal membrane oxygenation as a bridge to lung transplantation: a long-term study | Q47894658 |
| | The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension | Q48297443 |
| | Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation | Q48342765 |
| | Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension | Q49109045 |
| | Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome. | Q49821130 |
| | Outcomes of intraoperative venoarterial extracorporeal membrane oxygenation versus cardiopulmonary bypass during lung transplantation | Q50456441 |
| | Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass. | Q50504322 |
| | Right ventricular assist device use in ventricular failure due to pulmonary arterial hypertension: Lessons learned. | Q51128412 |
| | Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. | Q51366236 |
| | Extracorporeal membrane oxygenation watershed. | Q51698345 |
| | Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantation. | Q52322075 |
| | Central versus peripheral cannulation of extracorporeal membrane oxygenation support during double lung transplant for pulmonary hypertension. | Q52661113 |
| | Gut-Lung Connection in Pulmonary Arterial Hypertension. | Q52899598 |
| | Transient left ventricular failure following bilateral lung transplantation for pulmonary hypertension. | Q52911827 |
| | Reverse Right Ventricular Remodeling After Lung Transplantation in Patients With Pulmonary Arterial Hypertension Under Combination Therapy of Targeted Medical Drugs. | Q52924816 |
| | Vasopressin to attenuate pulmonary hypertension and improve systemic blood pressure after correction of obstructed total anomalous pulmonary venous return. | Q53872714 |
| | Right ventricular recovery after bilateral lung transplantation for pulmonary arterial hypertension†. | Q54699432 |
| | Endotoxin and immune activation in chronic heart failure: a prospective cohort study. | Q55033086 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pulmonary hypertension | Q1128595 |
| | lung transplant | Q1637912 |
| P304 | page(s) | 1801906 | |
| P577 | publication date | 2019-01-24 | |
| P1433 | published in | European Respiratory Journal | Q12257435 |
| P1476 | title | Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension | |
| P478 | volume | 53 | |